Overview
Oncology
Biography
Özlem Türeci is a German physician, scientist and entrepreneur. In 2008, she co-founded the biotechnology company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19. Türeci has served as BioNTech's chief medical officer since 2018. Since 2021, she has been Professor of Personalized Immunotherapy at the Helmholtz Institute for Translational Oncology (HI-TRON) and Johannes Gutenberg University Mainz. Türeci and her spouse, Uğur Şahin, have won a number of awards.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Published In
N Engl J MedNatureScienceNat Rev Drug Discov
Key Publications
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.
mRNA-based therapeutics--developing a new class of drugs.
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.
Areas of Expertise
Medical Specialties
Clinical Knowledge & Procedures
Media Archive